Authors
Latest:
Harbingers of ChangeThe industry is a-changing. Here are eight seminal events that describe how.
Latest:
Bridging Industry's Charisma ChasmPharma’s image is still suffering despite a rise in medical innovation. Dan Bobear offers five patient-centered strategies that could help in finally mending the gap.
Latest:
Valuing DiversityVeteran salesperson Reggie Smith of Genentech makes the case for sales force diversity
Latest:
The Changing World of Med EdFor years, medical education activities have been a sure way for pharma marketers to deliver key messages to the medical community about scientific discoveries, new treatments, and products fostering medical advancement. The most effective activities advance physicians' knowledge and motivate them to act.
Latest:
Generics Battle Heats UpThe competition for generics' 180-day marketing exclusivity is fierce, and Dr. Reddy's Laboratories filed the first court case calling into question FDA's methods for determining exclusivity on a patent-by-patent basis.
Latest:
Same Rod, Bigger FishAs pharmaceutical companies look to emerging markets to offset slowed growth at home, success will depend on efficient re-use of regulatory content to target new high-growth markets.
Latest:
Product Launch Strategies: Adapting Approaches in 2020 and BeyondWith new access levers emerging, positioning products will require a shift form the traditional launch playbook.
Latest:
A Better Way to BuildJust a few years ago, financiers were celebrating the "recession-proof" US economy, betting on the success of dot-coms and ridiculing the cautious few. Today, pharma industry experts tout mergers and acquisitions as a panacea to solve growth problems, reduce costs, increase sales, and renew R&D productivity.
Latest:
Capitalizing on Strategic Market InsightTo stay on top of a constantly evolving market that presents new challenges every day, product managers need to bolster branding strategies and raise their marketing IQ.
Latest:
Putting Predictive Market Research to the TestThere's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?
Latest:
How Not to Handle RebatesIn these cost cutting times, no drugmaker can afford to keep shoveling money down the Rebate Black Hole. Here's how to optimize your ROI and push back against the growing pressure of third-party rebates
Latest:
Ad(Ventures) in PharmalandDespite the downside in ad spend, an upside remains in the digital space that's wide open for exploration.
Latest:
Bridging the Talent Gap in GenericsThe hunt is on. Generic drug companies must find executives with the requisite capabilities for managing a global yet highly local business, and that can maintain the entrepreneurial culture on which their competitive advantage depends.
Latest:
Decision Making at Digital SpeedIn an era in which companies can forfeit $1 million each day they delay a product launch-and being second can mean failure-pharma executives are under pressure to make risk and opportunity decisions in less time than ever.
Latest:
The Buddy SystemJean-Marc Niemetz on forming partnerships with the industry's major stakeholders
Latest:
Combating CounterfeitsAfter last year's anthrax scare, people desperately began stockpiling Cipro (ciprofloxacin) and other products to prepare for bioterrorism attacks. Not wanting to bother with a visit to their doctor and not willing to pay the product's high retail price of several dollars a pill, they began ordering Cipro-or what they believed to be Cipro-online, from dozens of websites offering it at discounted rates. The problem is, there is no guarantee they were getting the real thing.
Latest:
The importance of pre-call planningPre-call planning is a necessity if you're going to move your physicians and your productivity to another level.
Latest:
Biopharma Trends in 2024 and BeyondGenerative artificial intelligence, key new product launches, and the evolution of the go-to-market model are among key trends to watch in the year ahead.
Latest:
Bridging the Talent Gap in GenericsThe hunt is on. Generic drug companies must find executives with the requisite capabilities for managing a global yet highly local business, and that can maintain the entrepreneurial culture on which their competitive advantage depends.
Latest:
e-Pedigree to the Next DegreeElectronic pedigree is the future of supply chain security. Those still waiting and seeing might what to stop waiting and start tracking
Latest:
Salesforce RoundtableIndustry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs
Latest:
Emotion - The New Brand IntegratorDriven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.
